دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
National crises and cancer control: challenges for Latin America and beyond
doi : 10.1016/S1470-2045(23)00022-0
Volume 24, Issue 2, February 2023, Page 117
Carfilzomib, lenalidomide, and dexamethasone maintenance for multiple myeloma: when and for whom?
*Monika Engelhardt, Ralph Wäsch
doi : 10.1016/S1470-2045(22)00792-6
Volume 24, Issue 2, February 2023, Pages 118-119
Randomised controlled trials are feasible in anaplastic thyroid cancer
*Livia Lamartina, Julien Hadoux
doi : 10.1016/S1470-2045(23)00006-2
Volume 24, Issue 2, February 2023, Pages 119-121
Are hemicolectomies justified for appendiceal neuroendocrine tumours smaller than 2 cm?
*Jonathan R Strosberg, Taymeyah Al-Toubah
doi : 10.1016/S1470-2045(22)00764-1
Volume 24, Issue 2, February 2023, Pages 121-122
On a precipice: the UK's broken health-care system
David Collingridge
doi : 10.1016/S1470-2045(22)00758-6
Volume 24, Issue 2, February 2023, Pages 122-123
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission
Raffaella Casolino, Amber L Johns, Melanie Courtot, Rita T Lawlor, Francesco De Lorenzo, Denis Horgan, Joaquin Mateo, Nicola Normanno, Mark Rubin, Lincoln Stein, Vivek Subbiah, Benedikt C Westphalen, Mark Lawler, Keunchil Park, Sandra Perdomo, Takayuki Yoshino, Jianmin Wu, Andrew V Biankin, on behalf of the Lancet Oncology Commission on Cancer Omics and Precision Oncology
doi : 10.1016/S1470-2045(23)00007-4
Volume 24, Issue 2, February 2023, Pages 123-125
International Radiation Oncology societies Network (IRON): a unified voice in addressing global cancer challenges
*Ben J Slotman, Thomas J Eichler
doi : 10.1016/S1470-2045(22)00648-9
Volume 24, Issue 2, February 2023, Pages 125-126
Thank you to The Lancet Oncology's reviewers in 2022
doi : 10.1016/S1470-2045(23)00024-4
Volume 24, Issue 2, February 2023, Pages e58-e64
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment?
Marco Bandini, Alessandro Nini, Alberto Briganti, Andrea Necchi, Francesco Montorsi
doi : 10.1016/S1470-2045(22)00743-4
Volume 24, Issue 2, February 2023, Page e65
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment? – Authors' reply
Alexandros Papachristofilou, Stefanie Hayoz, Richard Cathomas
doi : 10.1016/S1470-2045(22)00791-4
Volume 24, Issue 2, February 2023, Page e66
Essential medicines for childhood cancer in Europe
Yoram Unguru, Melanie Brooke Bernhardt, Stacey L Berg, Liza Marie-Johnson, Kim Pyke Grimm, Catherine Woodman, Conrad V Fernandez
doi : 10.1016/S1470-2045(23)00009-8
Volume 24, Issue 2, February 2023, Page e67
18F-NaF PET–CT versus 99mTc SPECT in bone metastasis assessment
*Jiazheng Wang, Richard L Hesketh
doi : 10.1016/S1470-2045(23)00003-7
Volume 24, Issue 2, February 2023, Page e68
18F-NaF PET–CT versus 99mTc SPECT in bone metastasis assessment – Authors' reply
François Bénard, Sara Harsini
doi : 10.1016/S1470-2045(23)00017-7
Volume 24, Issue 2, February 2023, Page e69
Adopting shorter radiation regimens: rules of engagement for sarcoma
Anusha Kalbasi
doi : 10.1016/S1470-2045(23)00008-6
Volume 24, Issue 2, February 2023, Page e70
Call to the UK Government for a radical new cancer recovery plan
*Tim Farron, Grahame Morris
doi : 10.1016/S1470-2045(22)00787-2
Volume 24, Issue 2, February 2023, Page e71
Correction to Lancet Oncol 2023; 24: 64–76
doi : 10.1016/S1470-2045(23)00025-6
Volume 24, Issue 2, February 2023, Page e72
Botswana plans first-ever national cancer control programme
Munyaradzi Makoni
doi : 10.1016/S1470-2045(22)00784-7
Volume 24, Issue 2, February 2023, Page 127
New collaborating centres in sub-Saharan Africa to improve cancer data access
Manjulika Das
doi : 10.1016/S1470-2045(22)00785-9
Volume 24, Issue 2, February 2023, Page 128
Africa's radiotherapy future gets funding boost
Elizabeth Gourd
doi : 10.1016/S1470-2045(22)00756-2
Volume 24, Issue 2, February 2023, Page 129
England almost a decade behind on smokefree 2030 target
Elizabeth Gourd
doi : 10.1016/S1470-2045(23)00004-9
Volume 24, Issue 2, February 2023, Page 130
Indonesia launches three programmes to boost cancer care
Manjulika Das
doi : 10.1016/S1470-2045(23)00010-4
Volume 24, Issue 2, February 2023, Page 131
New partnership to boost UK cancer vaccine research
Udani Samarasekera
doi : 10.1016/S1470-2045(23)00011-6
Volume 24, Issue 2, February 2023, Page 132
Firefighters at increased risk of cancer diagnosis
Elizabeth Gourd
doi : 10.1016/S1470-2045(23)00021-9
Volume 24, Issue 2, February 2023, Page e73
UK cancer care: a watershed moment and the need for urgent intervention
*Pat Price, Richard Sullivan, Amar Ahmed, Gordon C Wishart
doi : 10.1016/S1470-2045(22)00754-9
Volume 24, Issue 2, February 2023, Pages 133-138
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak, Tadeusz Kubicki, Paweł Robak, Adam Walter-Croneck, Jarosław Czyż, Agata Tyczyńska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Adam Nowicki, Tomasz Szczepaniak, Anna �ojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Puła, Justyna Rybka, Maciej Majcherek, Lidia Usnarska-Zubkiewicz, �ukasz Szukalski, Agnieszka Końska, Jan Maciej Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Oscar B Lahoud, Jeffrey A Zonder, Kent Griffith, Andrew Stefka, Ajay Major, Benjamin A Derman, Andrzej J Jakubowiak
doi : 10.1016/S1470-2045(22)00738-0
Volume 24, Issue 2, February 2023, Pages 139-150
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
Jingyuan Wang, Joanne Xiu, Alex Farrell, Yasmine Baca, Hiroyuki Arai, Francesca Battaglin, Natsuko Kawanishi, Shivani Soni, Wu Zhang, Joshua Millstein, Anthony F Shields, Axel Grothey, Benjamin A Weinberg, John L Marshall, Emil Lou, Moh’d Khushman, Davendra P S Sohal, Michael J Hall, Tianshu Liu, Matthew Oberley, David Spetzler, W Michael Korn, Lin Shen, Heinz-Josef Lenz
doi : 10.1016/S1470-2045(22)00783-5
Volume 24, Issue 2, February 2023, Pages 151-161
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial
Eve Rodler*, Priyanka Sharma*, William E Barlow, Julie R Gralow, Shannon L Puhalla, Carey K Anders, Lori Goldstein, Debu Tripathy, Ursa A Brown-Glaberman, Thu-Tam Huynh, Christopher S Szyarto, Andrew K Godwin, Harsh B Pathak, Elizabeth M Swisher, Marc R Radke, Kirsten M Timms, Danika L Lew, Jieling Miao, Lajos Pusztai, Daniel F Hayes, Gabriel N Hortobagyi
doi : 10.1016/S1470-2045(22)00739-2
Volume 24, Issue 2, February 2023, Pages 162-174
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein, Christine H Chung, Nadeem Riaz, G Brandon Gunn, Robert L Foote, Sue S Yom, Stuart J Wong, Shlomo A Koyfman, Michael F Dzeda, David A Clump, Saad A Khan, Manisha H Shah, Kevin Redmond, Pedro A Torres-Saavedra, Quynh-Thu Le, Nancy Y Lee
doi : 10.1016/S1470-2045(22)00763-X
Volume 24, Issue 2, February 2023, Pages 175-186
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study
édric Nesti, Konstantin Bräutigam, Marta Benavent, Laura Bernal, Hessa Boharoon, Johan Botling, Antonin Bouroumeau, Iva Brcic, Maximilian Brunner, Guillaume Cadiot, Maria Camara, Emanuel Christ, Thomas Clerici, Ashley K Clift, Hamish Clouston, Lorenzo Cobianchi, Jarosław B Ćwikła, Kosmas Daskalakis, Andrea Frilling, Rocio Garcia-Carbonero, Simona Grozinsky-Glasberg, Jorge Hernando, Valérie Hervieu, Johannes Hofland, Pernille Holmager, Frediano Inzani, Henning Jann, Paula Jimenez-Fonseca, Enes Kaçmaz, Daniel Kaemmerer, Gregory Kaltsas, Branislav Klimacek, Ulrich Knigge, Agnieszka Kolasińska-Ćwikła, Walter Kolb, Beata Kos-Kudła, Catarina Alisa Kunze, Stefania Landolfi, Stefano La Rosa, Carlos López López, Kerstin Lorenz, Maurice Matter, Peter Mazal, Claudia Mestre-Alagarda, Patricia Morales del Burgo, Els J M Nieveen van Dijkum, Kira Oleinikov, Lorenzo A Orci, Francesco Panzuto, Marianne Pavel, Marine Perrier, Henrik Mikael Reims, Guido Rindi, Anja Rinke, Maria Rinzivillo, Xavier Sagaert, Ilker Satiroglu, Andreas Selberherr, Alexander R Siebenhüner, Margot E T Tesselaar, Michael J Thalhammer, Espen Thiis-Evensen, Christos Toumpanakis, Timon Vandamme, José G van den Berg, Alessandro Vanoli, Marie-Louise F van Velthuysen, Chris Verslype, Stephan A Vorburger, Alessandro Lugli, John Ramage, Marcel Zwahlen, Aurel Perren*, Reto M Kaderli*
doi : 10.1016/S1470-2045(22)00750-1
Volume 24, Issue 2, February 2023, Pages 187-194
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
Subarnarekha Chatterji, Emma Krzoska*, Christopher W Thoroughgood*, John Saganty*, Peng Liu, Beatrix Elsberger, Rasha Abu-Eid, Valerie Speirs
doi : 10.1016/S1470-2045(22)00633-7
Volume 24, Issue 2, February 2023, Pages e74-e85
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group
Claire Piccinin, Ethan Basch, Vishal Bhatnagar, Melanie Calvert, Alicyn Campbell, David Cella, Charles S Cleeland, Corneel Coens, Anne-Sophie Darlington, Amylou C Dueck, Mogens Groenvold, Ralf Herold, Bellinda L King-Kallimanis, Paul G Kluetz, Dagmara Kuliś, Daniel O’Connor, Kathy Oliver, Madeline Pe, Bryce B Reeve, Jaap C Reijneveld, Xin Shelley Wang, Andrew Bottomley
doi : 10.1016/S1470-2045(22)00654-4
Volume 24, Issue 2, February 2023, Pages e86-e95
Pharmaceutical industry relationships with oncologists in sub-Saharan Africa
Fidel Rubagumya, Miriam Mutebi, Achille Manirakiza, Omar Abdihamid, Melinda Mushonga, Verna Vanderpuye, Nazik Hammad, Christopher M Booth
doi : 10.1016/S1470-2045(22)00639-8
Volume 24, Issue 2, February 2023, Pages e96-e101
Pseudoprogression of a cutaneous lung cancer metastasis
Yue-Mei Dong, Suo-Zhu Sun, Shan-Shan Ding, Huo-Ming Chen, Ning Wang
doi : 10.1016/S1470-2045(22)00552-6
Volume 24, Issue 2, February 2023, Page e102
